chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tremendous swelling; large rash; swelling and redness at the injection site; swelling and redness at the injection site; Itched; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (tremendous swelling), RASH (large rash), PRURITUS (Itched), VACCINATION SITE SWELLING (swelling and redness at the injection site) and VACCINATION SITE ERYTHEMA (swelling and redness at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced RASH (large rash), PRURITUS (Itched), VACCINATION SITE SWELLING (swelling and redness at the injection site) and VACCINATION SITE ERYTHEMA (swelling and redness at the injection site). On 09-Feb-2021, the patient experienced SWELLING (tremendous swelling). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, SWELLING (tremendous swelling), RASH (large rash), PRURITUS (Itched), VACCINATION SITE SWELLING (swelling and redness at the injection site) and VACCINATION SITE ERYTHEMA (swelling and redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details also included wet rag.
Having a fast heartbeat; Swelling in arm; Its just a little bit achy; This is a spontaneous report from a contactable consumer  reporting for herself.  A female patient of an unspecified age received bnt162b2 (BNT162B2; Lot # EH9899) vaccine , via an unspecified route of administration on 27Dec2020 10:00 at single dose for covid-19 immunisation.  The patient medical history was not reported.  Concomitant medication included metformin (METFORMIN), atorvastatin (ATORVASTATIN), ezetimibe (ZETIA), fenofibrate (FENOFIBRATE).  The patient experienced swelling in arm  on 27Dec2020 with outcome of unknown , having a fast heartbeat  on 28Dec2020 with outcome of unknown , its just a little bit achy on Dec2020 with outcome of unknown.  The patient underwent lab tests and procedures which included heart rate: fast   on 28Dec2020  .
Fever - 100 - 101;  aching; injection site is swollen and red and the area is getting larger since Wednesday, 10/1/14. Patient went to a walk-in clinic and was told by on call physician that the reaction was common.  She saw another physician whom prescribed her Bactrim ds (1 tablet by mouth twice daily for 10 days.)
pt received first dose of moderna and about 15-20 minutes into waiting her daughter mentioned her mother was experiencing redness of left hand. it did not itch, hurt or swell. She did not have redness anywhere else (we checked injection site arm and torso). she did not report any systemic reactions.  my partnering rph helped to administer 25mg oral benadryl liquid and I sat with our pt an additional 15-20 minutes. pt reported the benadryl was helping some but it was still al little redder than usual-her daughter said they would repeat benadryl dose at home and monitor.
Two patients that received Shingrix first dose almost a year ago; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 53-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 17th January 2020, almost a year ago). Concurrent medical conditions included peanut allergy, penicillin allergy and allergic reaction to analgesics. Concomitant products included cholesterol.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up by email. This case has been linked with US2021AMR085160, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR085160:Same reporter. Pt 2.
5/31 Patient arrived to ambulatory services for #4 injection. Patient stated last injection 5/24/05 made sores and blisters in his mouth and throat. Patient stated injection #2 did the same but not as severe. Patient's physician notified and patient was sent to his office. Injection declined.
SWELLING, REDNESS, HEAT, PAIN, COULD NOT LIFT ARM FOR 3 DAYS. PATIENT HAD STILL NOT RECOVERED BY DAY 7.
LEFT EYE WATERY, LEFT SIDE OF FACE TINGLING, PAIN IN LEFT EAR CANAL & BEHIND EAR, FACIAL DROOP ON LEFT SIDE STARTED WITHIN 30MINUTES OF VACCINE. FACIAL DROOP ONLY LASTING ~30 SECONDS ON 12/24, 25, 26.
Achy arm; Very sore; Feeling hot; Feeling cold; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Achy arm), PAIN (Very sore), FEELING HOT (Feeling hot), FEELING COLD (Feeling cold) and HEADACHE (Headache) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Achy arm), PAIN (Very sore), FEELING HOT (Feeling hot), FEELING COLD (Feeling cold) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Achy arm), PAIN (Very sore), FEELING HOT (Feeling hot), FEELING COLD (Feeling cold) and HEADACHE (Headache) outcome was unknown.            No relevant concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD21-051841, MOD21-051914 (Patient Link).
PT. REPORTS PAIN AT INJECTION SITE BEGINNING 8 DAYS AFTER VACCINATION.  STATED NO PAIN ON DAYS 1-7.  INDICATES PAIN BEGAN 8 DAYS AFTER VACCINATION AND IS WORSENING IN INTENSITY.  PATIENT IS TREATING WITH ADVIL.
20 YO FEMALE WITH HX OF ANXIETY WHICH MANIFESTS WITH INCREASE HR P/W CHEST STIFFNESS, INCREASE HR, LUMP ON THE THROAT 2 MINS AFTER RECEIVING 1ST DOSE OF COVID VACCINE.  HER LAST ANXIETY ATTACK WITH SIMILAR SYMPTOMS OCCURRED APPROX 1 YR AGO WHICH LASTED FOR HOURS AFTER FALLING ASLEEP.  SYMPTOMS WERE SELF LIMITING WITHOUT MEDS.  PT FELT IMPROVEMENTS UPON ARRIVING TO OBS 1 AREA.  NO LONGER HAVING CHEST TIGHTNESS OR LUMP ON THE THROAT HOWEVER STILL WITH INCREASE HR.  DENIES CHEST PAIN, SOB, DIZZINESS, SYNCOPE, RASH, HA, WEAKNESS, LIGHTHEADNESS, OR VERTIGO. VITALS: 1430 LAYING 143/83; 109; 98% 1437 1223/80, 97, 100%, RR 15 1504 SITTING 121/83; 103; 98% 1518 STANDING 124/84; 102; 99% HEART-  RRR; NO MURMUR; LUNGS- CTA; NO WHEEZING; CN2-12 INTACT;  5/5 MOTOR BUE AND BLE;  PT ABLE TO STAND AND AMBULATE WITHOUT ASSISTANCE.  FEELS MUCH BETTER BUT CAN STILL FEEL INCREASE HR; PT AND MOM DID NOT WANT TO GO TO THE ED/URGENT CARE;  STATES SHE FEELS BETTER AND ANTICPATES TO IMPROVE MORE AT HOME WIHT FURTHER REST. PT WAS ADVISED TO GO TO ED IF SYMPTOMS PERSISTS AT HOME OR WORSENS.  ADVISED TO ALSO CALL PCP IMMEDIATELY FOR THEIR GUIDANCE.   PT WALKED WITH HER MOM AND YOUNGER SISTER TO THE CAR WITH NO CONCERNS RELEASED TIME 1520
Developed severe headache/fever 36 hours later. Took 1000 mg Acetaminophen, That took care of fever/headache. Stayed home from work exhausted. 3rd day, still excessively fatigued. No energy. Stayed home from work. 4th day still extreme fatigue, no energy. Stayed home from work. 5th day extreme fatigue, no energy. Stayed home not working. 6th day stayed home, still tired, no energy, not working. 7th day went to work. Ran a fever at work, took 400 mg of Acetaminophen, fever was reduced. Stayed at work. 8th day went to work, almost fainted, weak, legs hurt. Tested negative for Covid-19. 9th day woke up dizzy, exhausted. Missed work.
Mom called into the office stating patient had a temp of 101.1 after receiving immunizations. Mom advised to give Tylenol for fever.
Shingles; This is a spontaneous report from a contactable nurse. A 92-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 30Jan2021 (Batch/Lot Number: Unknown) as SINGLE DOSE for covid-19 immunisation. Medical history included blood pressure. Concomitant medications included rivaroxaban (XARELTO) taken for an unspecified indication, start and stop date were not reported; levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported and an unspecified blood pressure medication.  The patient experienced shingles on an unspecified date too weeks later; he never had shingles before. The outcome of event was unknown. Therapeutic measures were taken as a result of shingles included "some cream".  Follow-up attempts are completed. The following information on the batch number has been requested.
PFIZER COVID VACCINE #3 GIVEN 9/8/21, LOT #FF2589; 1/13/22 pt to ED with increasing SOB and cough; states had a positive COVID test 2 days prior to coming to ED; sx have worsened; positive COVID test in ED; pt diaphoretic and c/o epigastric pain without radiation; found to have moderate to large pericardial effusion; during hospitalization, pt experienced cardiac arrest - repeat episodes; intubated; transferred to MICU; given IV ABX and IV pressors; family then made pt a DNR, comfort care; pt extubated and he passed away in the hospital
Severe pain in arm radiating to shoulder and back and restricting range of motion. Prednisone plus phys therapy 2xweek thru 1/28/16. Still not resolved.
Low grade fever, increased temp throughout the week, treated with Tylenol/Motrin.  Cough, decreased appetite.  Was seen by ARNP X2, on 11/11 & 11/13.
I had pain at the injection site a few hours after my second dose and that pain grew to a pain I had never felt before. It was in my arm , shoulder and neck. Around 16hrs after my shot I was in crippling pain throughout my entire body. Every single joint hurt to an enormous level. My muscles then felt like they were burning and I was bed ridden. I then got the chills and couldn?t keep my eyes open. A fatigue like no other. I did take OTC pain meds 2 times during the pain. All of this lasted 28hrs and then it was gone. Zero pain after that 28hrs. The pain I felt though was enough to make me nervous. I can handle pain and this was my n a whole other chart. It was miserable
This spontaneous report as received from a licensed practical nurse refers to multiple unspecified patients of unknown age and gender. Patient pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. On unknown dated these unspecified patients were vaccinated with improperly stored GARDASIL 9 (strength, dosing details, anatomical location, lot# and expiration date were unknown). There were previous temperature excursions but, no information was provided on previous excursions. The temperature excursions were detected by a data logger. No product quality complaint was involved. Additional information has been requested.
taste and smell changes. pt reports that items taste must worse than what they usually do and the taste/smell is off.
Fogginess, headache, sore arm, stiff neck on left side, very fatigue
covid arm; site of injection is itching; red mark (8 cm long and 8 cm wide); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm), INJECTION SITE PRURITUS (site of injection is itching) and INJECTION SITE ERYTHEMA (red mark (8 cm long and 8 cm wide)) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 immunization.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE REACTION (covid arm), INJECTION SITE PRURITUS (site of injection is itching) and INJECTION SITE ERYTHEMA (red mark (8 cm long and 8 cm wide)). At the time of the report, VACCINATION SITE REACTION (covid arm), INJECTION SITE PRURITUS (site of injection is itching) and INJECTION SITE ERYTHEMA (red mark (8 cm long and 8 cm wide)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Hospital Course   69-year-old female with past medical history of atrial fibrillation cardiomyopathy (last EF's 71% on 12/2 & 50% 02/21), myasthenia gravis transferred from Hospital for vertebral osteomyelitis and MSSA bacteremia, atrial fib and altered mental status. Admitted on 11/4 and has since been receiving medical management of vertebral osteomyelitis/discitis/epidural abscess at L1-L3. Has had multiple medications and changes since admission with her current medication being cefazolin. Hospital course has been very complicated with patient first developing C. diff colitis and treated with oral vancomycin and subsequently continued on prophylaxis dosing. She also developing AHRF on 12/01 secondary to COVID requiring NIPPV. 12/02 patient's respiratory status continued to decline and patient was intubated with consent from her brother. Neurology was consulted due to her altered mental status and concern that her myasthenia was contributing. They were able to recommend downtitrating her mycophenalate and pyridostigamine and holding prednisone. Patient had refractory acidosis and started on SLED but was unable to tolerate it initially but has been able to tolerate CRRT and CVVHDF. Patient has also been complicated with concerns for HIT; however, studies are not suggestive and argatroban drip was discontinued. Also has been in atrial fibrillation. Lastly, patient's Hgb dopped and CT abdomen was down which showed pancreatitis and peripancreatic/retroperitoneal fluid collection with some blood products. GI consulted and feel that pancreatitis was likely due to COVID19. Due to the continued deterioration of the patient's condition despite maximal medical effort, patient's brother, with discussion with palliative medicine, decided to pursue comfort care. patient was placed on comfort care 12/14 and expired 17:21. Family was contacted, declines autopsy.
7PM pt began to feel hot, irritable; 730 mom gave APAP, t101.2 @ that time; 830PM temp elevated 103; gave 20 mins tepid bath; temp elevated 103.4; eye swollen, red rash; MD stated rxn to MMR; glands & eyes swollen
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 15-OCT-2018,  the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R000554 with expiration date 08-JAN-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA0103031: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
Chills then sweating, muscle aches, headache, nausea, vomiting, abdominal pain, fatigue.
Erythema, swelling at site on left arm. Began to react during first 24 hours.
Excerpt taken from patient's medical record notes.    Recreational Therapist was in room with patient who was at baseline mentation at that time, and was getting patient a cup of tea.  Rec Therapist observed patient to "all of a sudden slouch down toward left side" and became unresponsive.  Therapist called for help, and Registered Nurse (RN) and Certified Nurse Aide (CNA) came into room.  Patient was initially non-responsive and profusely sweating and hot to touch.  Vitals  were taken (see below).  The patient then slowly became responsive after approximately 4 minutes and was visibly nauseous  and appeared like she was going to vomit, but ultimately did not.  Patient was assisted into bed, APRN was called, order for vital signs to be taken every 4 hours for 72 hours, and Electrocardiogram (EKG) to be performed.   EKG results were abnormal, indicative of infarct; APRN ordered transport to Emergency Department.   Patient returned from Hospital ED at approximately 10:45 PM same day (1/28/21), with transfer paperwork documenting  a  Hospital diagnosis of "Syncope" without any additional lab results or any new medication or treatment orders in the documentation.  Follow up the next day (1/29/21) by RN at the Nursing Facility--RN logged into the Hospital medical Charting system, only to find that there was no record whatsoever of the patient being in the Emergency Department on 1/28/21--no notes, no labs, no summary from a practitioner.  Patient recovered and has resumed close-to-baseline activity and functioning.
Urticaria- I have had hives and intense itching burning and welts all over my body since initial reaction everyday .
hair breakage; excessive hair loss; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TRICHORRHEXIS (non-serious), outcome "unknown", described as "hair breakage"; ALOPECIA (non-serious), outcome "unknown", described as "excessive hair loss". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101599235 same reporter/drug/event, different pt;US-PFIZER INC-202101595686 same reporter/drug/event, different pt
On 8/25/2020 - Over 24 hours, Patient had vomiting, fussiness, lethargy that progressed to bilious vomiting.  He was found to have intussusception.  This has been previously linked to the Rotavirus Vaccine.
Shortly after the injection I started feeling light headed.. as the 15 minute window went on I also got super dizzy and my vision started going out.. a few minutes after that happened my chest started tightening up and my breathing became very labored and difficult. They hospital staff came and checked my vitals and gave me Benadryl. They put me on a stretcher and rushed me down to the er.
I started to feel pain in both knees going down both legs around 4/1/21.  An ultrasound was performed and a blood clot was found in my left lower leg.
Patient received his first VARIVAX immuniz. 7/22/2014 without incident. On 8/22/14 patient given his second VARIVAX injection. 5 min. later developed facial puffiness/itching and hives on his back. Lasted 90 mins.; took 25mg BENADRYL.
2 1/2 weeks after first dose of vaccine I developed muscle and joint pain that continues.  The pain became more intense several days after the second dose of the Pfizer vaccine I received on 02/13/2021
Site: Swelling at Injection Site-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: severe swelling of right arm and hand-Severe
Information has been received from a registered nurse concerning unspecified patients of unknown age and gender. The patients' concurrent conditions, medical histories and concomitant therapies were not reported. From 08-AUG-2017 to 22-AUG-2017, the patients were vaccinated with improperly stored  M-M-R II (lot # M044351 with expiration date 04-NOV-2018; dose and route were unknown, for prophylaxis) which were  exposed to temperature excursion of 9 to 25 degrees Celsius for 1 hours 34 minutes. There were no previous temperature excursions. Data logger was involved. No adverse reactions were reported. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1708USA010405: US-009507513-1708USA010404: US-009507513-1708USA010408: US-009507513-1708USA010406: US-009507513-1708USA010242:
Expired vaccine administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 18-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 575HC, expiry date 28-FEB-2023) for prophylaxis.   On 25-APR-2023, the patient received Boostrix. On 25-APR-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Expired vaccine administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 01-MAY-2023 The vaccine administration facility was the same as primary reporter. The reporter consented to follow up via postal. The patient was administered expired Boostrix vaccine which led to expired vaccine used.